Harnessing AI and Real-World Evidence to Advance Alzheimer’s Screening and Equitable Access
Explore how AI-driven real-world data reveals trends in Alzheimer’s screening, testing, and treatment—and highlights where inequities persist.
Explore how AI-driven real-world data reveals trends in Alzheimer’s screening, testing, and treatment—and highlights where inequities persist.
This session will explore Part 2 of our 3-part MAPS series turns insight into action. In Part 1, we unpacked Daniel Goleman’s five elements of Emotional Intelligence (EI). Now we put EI to work.
EvGen strategies via CSS are stretched, prompting companies to use ESR more strategically, including for registration and signal-seeking.
This webinar will explore how new approaches are transforming evidence generation for registries and studies by leveraging structured and unstructured electronic health records, creating flexible, living platforms that adapt as new standards of care and questions emerge.
Join our experts who will be covering the burning platform that is early stage drug development, listen and ask them questions on their thoughts on the role of Medical Affairs in early-stage drug development.
This session will explore the five elements of emotional intelligence—self-awareness, self-regulation, motivation, empathy, and social skills—and how they can be harnessed to build resilient, high-performing Medical Affairs teams.
This session will explore the five elements of emotional intelligence—self-awareness, self-regulation, motivation, empathy, and social skills—and how they can be harnessed to build resilient, high-performing Medical Affairs teams.
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
The session will walk attendees through how pillars of impact—Impact Story, Contributions, and Execution—were used to translate high-level strategy into tangible action.
The rise in rare diseases and personalized medicine has heightened the need to understand natural history and treatment pathways for unique patient populations.
